Fairmount Funds Management Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Fairmount Funds Management Llc disclosed 10 stock positions valued at approximately $1.51B as of quarter-end June 30, 2026. The largest holdings include ORUKA THERAPEUTICS INC, DIANTHUS THERAPEUTICS INC, and COGENT BIOSCIENCES INC.

Report Period
June 30, 2026
No. of Stocks
10
Portfolio Value
$1.51B
Holdings by Sector
Fairmount Funds Management Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ORUKA THERAPEUTICS INCORKAOther23.31%3,705,262--$352,629,785
DIANTHUS THERAPEUTICS INCDNTHHealthcare16.35%2,537,191--$247,325,379
COGENT BIOSCIENCES INCCOGTHealthcare14.08%5,503,418--$212,982,277
JADE BIOSCIENCES INCJBIOOther6.69%4,553,494--$101,178,637
ENLIVEN THERAPEUTICS INCELVNHealthcare6.22%1,855,644--$94,173,933
VIRIDIAN THERAPEUTICS INCVRDNHealthcare6.18%5,090,928+1,176,470+30.05%$93,520,347
ZENAS BIOPHARMA INCZBIOOther3.96%2,359,025--$59,872,055
APOGEE THERAPEUTICS INCAPGEHealthcare2.62%298,647--$39,639,416
FAETH THERAPEUTICS INCFTHOther1.19%722,020+722,020+100.00%$18,050,500
INHIBIKASE THERAPEUTICS INCIKTHealthcare1.16%8,625,000--$17,508,750
Showing 10 of 10 holdings in the latest reporting period.
Fairmount Funds Management Llc Portfolio Stock Holdings | InsiderSet